SECsense Logo

Aptose Biosciences Inc. 8-K Report: Key Insights & Developments (Feb 18, 2025)

$APTO
Form 8-K
Filed on: 2025-02-21
Source
Aptose Biosciences Inc. 8-K Report: Key Insights & Developments (Feb 18, 2025)

Based on the provided section of the financial report, here are the key insights extracted:

  1. Company Identification:
  • Entity Name: Aptose Biosciences Inc.
  • CIK (Central Index Key): 0000882361
  • SEC File Number: 001-32001
  • EIN (Employer Identification Number): 98-1136802
  1. Address:
  • Location: 66 Wellington Street West, Suite 5300, TD Bank Tower, Box 48, Toronto, ON M5K 1E6, Canada
  • Contact Number: (647) 479-9828
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: February 18, 2025
  1. Market Information:
  • Exchange Listing: NASDAQ
  • Security Type: Common Shares, no par value
  1. Period of Report:
  • Report Date: The report covers a duration from February 18, 2025, to February 18, 2025, indicating it may be a specific event or announcement on that date.
  1. Schema Reference:
  • The report references an XBRL schema file named apto-20250218.xsd, which may contain further structured data relevant to the filing.

Summary:

Aptose Biosciences Inc. filed an 8-K report with the SEC on February 18, 2025, detailing information pertinent to the company as of that date. The company is based in Toronto, Canada, and trades on NASDAQ. The report's context suggests it may include significant events or corporate developments relevant to investors.

This analysis captures essential identifiers, filing details, and the context of the report, providing a succinct overview for stakeholders looking into Aptose Biosciences Inc.'s recent activities.